Abeona Therapeutics Inc

0.00 (+0.12%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Abeona Therapeutics Inc Stock, NASDAQ:ABEO

1330 Avenue of the Americas, 33rd floor, New York, New York 10019
United States of America
Phone: +1.646.813.4701
Number of Employees: 76


Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.